Logo (Actavis) 855 (Guanfacine Hydrochloride Extended-Release 4 mg)
Pill with imprint Logo (Actavis) 855 is Yellow, Elliptical/Oval and has been identified as Guanfacine Hydrochloride Extended-Release 4 mg. It is supplied by Actavis Pharma, Inc.
Guanfacine is used in the treatment of adhd; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 855
Guanfacine Hydrochloride Extended-Release
- Imprint
- Logo (Actavis) 855
- Strength
- 4 mg
- Color
- Yellow
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
fumaric acid,
hypromelloses,
lactose monohydrate,
microcrystalline cellulose,
povidone,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-2855 | Actavis Pharma, Inc. |
| 42291-0327 | AvKare, Inc. |
More about guanfacine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (279)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: antiadrenergic agents, centrally acting
Patient resources
- Drug Information
- Guanfacine (Advanced Reading)
- Guanfacine Extended-Release Tablets
- Guanfacine Tablets
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.